Market Overview:
The global antibody services market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for monoclonal antibodies and polyclonal antibodies, rising prevalence of chronic diseases, and growing number of biotechnology and pharmaceutical companies. The global antibody services market is segmented on the basis of type into monoclonal antibodies, polyclonal antibodies, and others. Monoclonal antibodies are expected to account for the largest share in this market due to their high specificity and affinity towards antigens. Polyclonal antibodies are also expected to witness significant growth during the forecast period due to their low cost as compared to monoclonal antibodies and increasing use in research applications. On the basis of application, this market is segmented into bioScience companies, bioScience research institutions, hospitals, other end users such as contract research organizations (CROs) and clinical trial centers), etc. BioScience companies are expected to account for the largest share in this market owingto their need for large quantities of high-quality custom-made monoclonal or polyclonal antibody products across all stages of drug development from discovery through commercialization.
Product Definition:
The term "antibody services" generally refers to the process of producing custom antibodies for research or diagnostic use. Antibodies are proteins that are produced by the body's immune system in response to foreign invaders, such as bacteria or viruses. They can be used to detect and identify these invaders, as well as other molecules related to disease.
Monoclonal:
Monoclonal antibodies are a specific type of antibody. They are produced by the B cell (B lymphocytes) in response to antigen. The B cells travel from the bone marrow to enter the blood stream and then attack and destroy germs or cancerous cells with high efficiency.
The most common types of cancers that develop into metastatic tumors which can then spread to other organs include breast cancer, lung cancer, skin melanoma, prostate carcinoma & liver carcinoma among others.
Polyclonal:
Polyclonal antibodies are made by the immune system and they are responsible for recognizing and binding to one specific antigen. They occur in two types, natural or human type, which is produced by the body's immune system and synthetic or laboratory manufactured type. Polyclonal antibodies can recognize multiple antigens on a single molecule however; they cannot distinguish between similar molecules such as that of an identical protein.
Application Insights:
The market is segmented by application into bio-science companies, bio-science research institutions, hospitals and others. The hospitals segment dominated the global market in 2017 owing to factors such as increasing prevalence of infectious diseases and rising healthcare expenditure. Antibody services are used for treatment of various autoimmune disorders at this level as well.
Bio-science companies were the largest revenue generating centers in 2017 due to high usage rates of antibodies in drug discovery and development processes across various industries such as food & beverage, diagnostics/labelling etc. Increasing R&D activities pertaining to biologics production have resulted in growth of this industry over the past few years which is expected to continue through 2030 with a CAGR around 11% from 2018 to 2030.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and biopharmaceutical companies, which are engaged in drug discovery and development, has resulted in the high demand for antibodies services. In addition, increasing government funding for R&D activities pertaining to immunology-based research is expected to fuel the growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure coupled with rising investments by international players aimed at capitalizing on this opportunity. Moreover, an increase in disease prevalence levels due to urbanization and changing lifestyle habits will boost revenue generation from 2018 to 2030 in this region.
Growth Factors:
- Increasing demand for monoclonal antibodies for therapeutic and diagnostic applications
- Growing prevalence of cancer and other chronic diseases
- Rising investments in life sciences sector
- Proliferation of biotechnology and pharmaceutical companies
- Technological advancements in antibody production
Scope Of The Report
Report Attributes
Report Details
Report Title
Antibody Services Market Research Report
By Type
Monoclonal, Polyclonal, Others, Antibody Service
By Application
BioScience Companies, BioScience Research Institutions, Hospitals, Other
By Companies
ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad, Covance, Capra Science, Innovagen, APS, Randox, GL Biochem, Abgent, Antibody Service
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Antibody Services Market Report Segments:
The global Antibody Services market is segmented on the basis of:
Types
Monoclonal, Polyclonal, Others, Antibody Service
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
BioScience Companies, BioScience Research Institutions, Hospitals, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ThermoFisher
- GenScript
- Abcam
- MBS
- ROCKLAND
- ProSci
- Anaspec
- Bio-Rad
- Covance
- Capra Science
- Innovagen
- APS
- Randox
- GL Biochem
- Abgent
- Antibody Service
Highlights of The Antibody Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal
- Polyclonal
- Others
- Antibody Service
- By Application:
- BioScience Companies
- BioScience Research Institutions
- Hospitals
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antibody Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antibody Services is a company that provides antibody testing and other immunology services.
Some of the major players in the antibody services market are ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad, Covance, Capra Science, Innovagen, APS, Randox, GL Biochem, Abgent, Antibody Service.
The antibody services market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Antibody Services Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Antibody Services Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Antibody Services Market - Supply Chain
4.5. Global Antibody Services Market Forecast
4.5.1. Antibody Services Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Antibody Services Market Size (000 Units) and Y-o-Y Growth
4.5.3. Antibody Services Market Absolute $ Opportunity
5. Global Antibody Services Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Antibody Services Market Size and Volume Forecast by Type
5.3.1. Monoclonal
5.3.2. Polyclonal
5.3.3. Others
5.3.4. Antibody Service
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Antibody Services Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Antibody Services Market Size and Volume Forecast by Application
6.3.1. BioScience Companies
6.3.2. BioScience Research Institutions
6.3.3. Hospitals
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Antibody Services Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Antibody Services Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Antibody Services Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Antibody Services Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Antibody Services Demand Share Forecast, 2019-2026
9. North America Antibody Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Antibody Services Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Antibody Services Market Size and Volume Forecast by Application
9.4.1. BioScience Companies
9.4.2. BioScience Research Institutions
9.4.3. Hospitals
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Antibody Services Market Size and Volume Forecast by Type
9.7.1. Monoclonal
9.7.2. Polyclonal
9.7.3. Others
9.7.4. Antibody Service
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Antibody Services Demand Share Forecast, 2019-2026
10. Latin America Antibody Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Antibody Services Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Antibody Services Market Size and Volume Forecast by Application
10.4.1. BioScience Companies
10.4.2. BioScience Research Institutions
10.4.3. Hospitals
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Antibody Services Market Size and Volume Forecast by Type
10.7.1. Monoclonal
10.7.2. Polyclonal
10.7.3. Others
10.7.4. Antibody Service
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Antibody Services Demand Share Forecast, 2019-2026
11. Europe Antibody Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Antibody Services Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Antibody Services Market Size and Volume Forecast by Application
11.4.1. BioScience Companies
11.4.2. BioScience Research Institutions
11.4.3. Hospitals
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Antibody Services Market Size and Volume Forecast by Type
11.7.1. Monoclonal
11.7.2. Polyclonal
11.7.3. Others
11.7.4. Antibody Service
11.8. Basi Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Antibody Services Demand Share, 2019-2026
12. Asia Pacific Antibody Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Antibody Services Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Antibody Services Market Size and Volume Forecast by Application
12.4.1. BioScience Companies
12.4.2. BioScience Research Institutions
12.4.3. Hospitals
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Antibody Services Market Size and Volume Forecast by Type
12.7.1. Monoclonal
12.7.2. Polyclonal
12.7.3. Others
12.7.4. Antibody Service
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Antibody Services Demand Share, 2019-2026
13. Middle East & Africa Antibody Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Antibody Services Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Antibody Services Market Size and Volume Forecast by Application
13.4.1. BioScience Companies
13.4.2. BioScience Research Institutions
13.4.3. Hospitals
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Antibody Services Market Size and Volume Forecast by Type
13.7.1. Monoclonal
13.7.2. Polyclonal
13.7.3. Others
13.7.4. Antibody Service
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Antibody Services Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Antibody Services Market: Market Share Analysis
14.2. Antibody Services Distributors and Customers
14.3. Antibody Services Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ThermoFisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GenScript
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abcam
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. MBS
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ROCKLAND
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ProSci
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Anaspec
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bio-Rad
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Covance
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Capra Science
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Innovagen
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. APS
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Randox
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. GL Biochem
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Abgent
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Antibody Service
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook